Effect of Different SARS-CoV-2 Vaccine Schedules and Vaccination Intervals on Reactogenicity and Humoral Immunogenicity

NCT05076227 · clinicaltrials.gov ↗

COMPLETED

Status

1206

Enrollment

OTHER

Sponsor class

Conditions

SARS-CoV2 Infection
Immunisation Reaction
Antibody Hypersensitivity
Tolerance

Interventions

DRUG: IM injection of vaccination (mRNA vaccination)
DRUG: IM injection of vaccination (vector based vaccination)

Sponsor

Serge Thal